🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Turkey / NCT06868784
Enrolling by invitation Observational

Investigation of the Relationship Between Executive Functions and Occupational Performance of Children With Duchenne Muscular Dystrophy

NCT06868784 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2025-03-01
Last updated
2026-02-23

Condition(s) studied

Executive DysfunctionOccupational ProblemsDuchenne Muscular Dystrophy

Investigational drug(s) / intervention(s)

Evaluations

Evaluations: Evaluations of executive functions and occupational performance

Study summary

The effects of Duchenne muscular dystrophy and its treatments on executive functions and occupational performance are under-mentioned in the literature. The researches believe that developmental and cognitive research is needed to identify interventions for children with DMD to identify and adapt to both individual and social environments, including self-care, productivity and leisure activities. Therefore, the aim of this study was to examine executive functions and occupational performance in children with DMD and compare them with healthy controls.

Eligibility

Sex
MALE
Min age
6 Years
Max age
12 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Being diagnosed with DMD * Volunteering to participate in the study by their parents and reading and signing the informed consent form Exclusion Criteria: * Having a neuromuscular disease other than DMD and/or another diagnosed neuromuscular disease accompanying DMD * The family and/or the child has problems with cooperation in completing the assessments for any reason * Difficulty understanding and speaking the Turkish language

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Lokman Hekim University Ankara Çankaya

More Lokman Hekim University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06868784 on ClinicalTrials.gov ↗ ← All trials in Turkey